16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rift Valley Fever (RVF) is an emerging zoonotic arbovirus with a complex cycle of transmission that makes difficult the prediction of its expansion. Recent outbreaks outside Africa have led to rediscover the human disease but it remains poorly known. The wide spectrum of acute and delayed manifestations with potential unfavorable outcome much complicate the management of suspected cases and prediction of morbidity and mortality during an outbreak. We reviewed literature data on bio-clinical characteristics and treatments of RVF human illness. We identified gaps in the field and provided a practical algorithm to assist clinicians in the cases assessment, determination of setting of care and prolonged follow-up.

          Related collections

          Most cited references90

          • Record: found
          • Abstract: not found
          • Article: not found

          Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics.

            This cohort descriptive study summarizes the epidemiological, clinical, and laboratory characteristics of the Rift Valley fever (RVF) epidemic that occurred in Saudi Arabia from 26 August 2000 through 22 September 2001. A total of 886 cases were reported. Of 834 reported cases for which laboratory results were available, 81.9% were laboratory confirmed, of which 51.1% were positive for only RVF immunoglobulin M, 35.7% were positive for only RVF antigen, and 13.2% were positive for both. The mean age (+/- standard deviation) was 46.9+/-19.4 years, and the ratio of male to female patients was 4:1. Clinical and laboratory features included fever (92.6% of patients), nausea (59.4%), vomiting (52.6%), abdominal pain (38.0%), diarrhea (22.1%), jaundice (18.1%), neurological manifestations (17.1%), hemorrhagic manifestations (7.1%), vision loss or scotomas (1.5%), elevated liver enzyme levels (98%), elevated lactate dehydrogenase level (60.2%), thrombocytopenia (38.4%), leukopenia (39.7%), renal impairment or failure (27.8%), elevated creatine kinase level (27.3%), and severe anemia (15.1%). The mortality rate was 13.9%. Bleeding, neurological manifestations, and jaundice were independently associated with a high mortality rate. Patients with leukopenia had significantly a lower mortality rate than did those with a normal or high leukocyte count (2.3% vs. 27.9%; odds ratio, 0.09; 95% confidence interval, 0.01-0.63).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98

              In December 1997, 170 hemorrhagic fever-associated deaths were reported in Carissa District, Kenya. Laboratory testing identified evidence of acute Rift Valley fever virus (RVFV). Of the 171 persons enrolled in a cross-sectional study, 31(18%) were anti-RVFV immunoglobulin (Ig) M positive. An age-adjusted IgM antibody prevalence of 14% was estimated for the district. We estimate approximately 27,500 infections occurred in Garissa District, making this the largest recorded outbreak of RVFV in East Africa. In multivariate analysis, contact with sheep body fluids and sheltering livestock in one’s home were significantly associated with infection. Direct contact with animals, particularly contact with sheep body fluids, was the most important modifiable risk factor for RVFV infection. Public education during epizootics may reduce human illness and deaths associated with future outbreaks.
                Bookmark

                Author and article information

                Contributors
                emilie.javelle@gmail.com
                Journal
                Ann Clin Microbiol Antimicrob
                Ann. Clin. Microbiol. Antimicrob
                Annals of Clinical Microbiology and Antimicrobials
                BioMed Central (London )
                1476-0711
                22 January 2020
                22 January 2020
                2020
                : 19
                : 4
                Affiliations
                [1 ]ISNI 0000 0001 0029 7279, GRID grid.414005.4, Laveran Military Teaching Hospital, ; CS500413384, Marseille Cedex 13, France
                [2 ]ISNI 0000 0001 2176 4817, GRID grid.5399.6, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, , Aix Marseille Univ, ; Marseille, France
                [3 ]French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France
                [4 ]ISNI 0000 0001 2176 4817, GRID grid.5399.6, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, , Aix Marseille Univ, ; Marseille, France
                [5 ]French Military Health Service, RSMA Medical Unit, Paris, Mayotte France
                [6 ]ISNI 0000 0004 0519 5986, GRID grid.483853.1, French Armed Forces Biomedical Research Institute (IRBA)-CNR des arbovirus-IHU Méditerranée Infection, ; Marseille, France
                [7 ]ISNI 0000 0001 2176 4817, GRID grid.5399.6, IRD 190, Inserm 1207, IHU Méditerranée Infection, AP-HM, , UVE, Aix-Marseille Univ, ; Marseille, France
                Article
                346
                10.1186/s12941-020-0346-5
                6977312
                31969141
                193e282c-bf57-47de-a54f-23e9dd89902e
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 18 July 2019
                : 12 January 2020
                Categories
                Review
                Custom metadata
                © The Author(s) 2020

                Infectious disease & Microbiology
                rift valley fever,human disease,management,algorithm
                Infectious disease & Microbiology
                rift valley fever, human disease, management, algorithm

                Comments

                Comment on this article